Home › Funds › Propel Bio Management, LLC › ACHV

Propel Bio Management, LLC position in ACHV

ACHIEVE LIFE SCIENCE INC · Health Care

Propel Bio Management, LLC reported holding 3,864,148 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q3 2026 13F filing — a position valued at US$31.3M, representing 16.57% of its reported portfolio and ranking #2 among its reported holdings. Propel Bio Management, LLC has disclosed ACHV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)3.86M sh
Reported value held$31.26M
Portfolio Weight16.57%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's ACHV position evolved

Propel Bio Management, LLC first disclosed a stake in ACHV in Q1 2024 at 2,453,092 shares (US$11.1M). The position peaked in Q3 2026 at 3,864,148 shares, worth US$31.3M. Across 11 filings, Propel Bio Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 3,864,148 shares valued at US$31.3M — a reduction of -169,870 shares quarter over quarter.. Notable position changes include a 151% increase in Q2 2025 (shares rose 39% over the following quarter), a 38% trim in Q3 2025 (shares rose 58% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.45M $11.15M New
Q2 2024 2.45M $11.53M Hold
Q3 2024 2.45M $11.63M Hold
Q4 2024 2.45M $8.63M Hold
Q1 2025 2.45M $6.55M Hold
Q2 2025 6.15M $13.91M Add
Q3 2025 3.79M $11.93M Reduce
Q4 2025 3.79M $18.82M Hold
Q1 2026 3.79M $11.37M Hold
Q2 2026 4.03M $26.34M Add
Q3 2026 3.86M $31.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACHV and 13F data

ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 68 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), venBio Partners LLC (US$38.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACHV

All ACHV fund holders →

FAQ

How long has Propel Bio Management, LLC held ACHV?

Propel Bio Management, LLC has disclosed ACHV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Propel Bio Management, LLC's current position in ACHV?

As of Q3 2026, Propel Bio Management, LLC holds 3.86M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $31.26M, representing 16.57% of its reported portfolio and ranking #2.

Has Propel Bio Management, LLC been buying or selling ACHV?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in ACHV. The position peaked in Q3 2026 at 3.86M shares.

Which other funds hold ACHV?

Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.